Skip to main content
Clinical Trials/NCT01629056
NCT01629056CompletedPhase 4

The Contact-PVI Study - Does Assessment of Tissue Contact During RF Ablation Using the St. Jude Medical™ Ensite™ Contact™ System Increase Rates of Long-term Pulmonary Vein Isolation? A Prospective Randomised Study

Oxford University Hospitals NHS Trust2 sites in 1 country148 target enrollmentStarted: January 2012Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Phase 4
Status
Completed
Enrollment
148
Locations
2
Primary Endpoint
The primary outcome measure will be the proportion (%) of pulmonary vein pairs found to be reconnected electrically to the left atrium at a subsequent redo ablation procedure

Study Overview

Brief Summary

This study aims to investigate the benefit of a new impedance-based computer software application during routine catheter ablation for atrial fibrillation, to see if this information improves short and long term electrical disconnection of the pulmonary veins. This study will be a single blind prospective randomised control trial in patients undergoing AF ablation. Study participants will be randomly assigned to undergo parts of their pulmonary vein ablation with, and parts of their ablation without tissue contact data displayed for the doctor performing the ablation to see. The pulmonary veins will then be studied at the end of the procedure, and at any repeat procedure in the future, to look for a difference in the recovery rate of the ablations performed using contact data, compared to those ablations performed without the use of this contact data. If a reduction in tissue recovery is achieved through the use of this tissue contact data, it may lead in the future to a reduced need for repeat ablation procedures, and better outcomes for patients.

The investigators hypothesise that the use of the Ensite™ Contact™ ECI data will reduce the recovery of conduction, and promote long-term pulmonary vein isolation in patients undergoing left atrial ablation for atrial fibrillation.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Care Provider)

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Participant is undergoing de novo pulmonary vein isolation procedure.
  • Participant is willing and able to give informed consent for participation in the study.
  • Male or Female, ≥18 years of age.

Exclusion Criteria

  • Previous percutaneous or open surgical procedure involving the left atrium
  • Pregnancy (current or currently planning)

Arms & Interventions

Contact ECI active

Active Comparator

Contact ECI active

Intervention: ablation (Procedure)

Contact information deactivated

Placebo Comparator

RF ablation without contact data

Intervention: RF ablation (Procedure)

Outcomes

Primary Outcomes

The primary outcome measure will be the proportion (%) of pulmonary vein pairs found to be reconnected electrically to the left atrium at a subsequent redo ablation procedure

Time Frame: 6 months

Secondary Outcomes

  • touch-up ablation requirements(acute (intra-procedure))
  • anatomical location of reconnections at repeat procedure(at repeat ablation procerdure (6-12 months post index ablation procedure))
  • complications(acute and subacute (intra-procedure, and during entire follow-up period))
  • Proportion of acute venous electrical reconnections(acute (intra-procedure))
  • RF time(acute (intra-procedure))
  • procedure time(acute)
  • amount of RF required to achieve re-isolation at repeat ablation procedure(at repeat ablation procedure (6-12 months post-index ablation procedure))

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials